[Are « complementary » cancer therapies actually indirectly harmful?]

Area of Science:

• Oncology
• Integrative Medicine
• Clinical Research

Background:

• Complementary therapies are increasingly used by cancer patients.
• The impact of complementary therapies on cancer patient outcomes requires careful evaluation.
• Adherence to conventional cancer treatment is critical for patient prognosis.

Purpose of the Study:

• To investigate the association between complementary therapy use and outcomes in cancer patients.
• To identify potential mechanisms explaining the observed outcomes.
• To inform clinical recommendations regarding complementary therapy use in oncology.

Main Methods:

• Analysis of data from a recent study on cancer patients.
• Comparison of outcomes between patients using complementary therapies and those not.
• Assessment of adherence to conventional cancer treatments.

Main Results:

• Cancer patients using complementary therapies concurrently with conventional treatment showed distinctly worse outcomes.
• A significant correlation was found between complementary therapy use and increased refusal of conventional treatment components.
• The negative effects observed were primarily attributed to reduced adherence to evidence-based anti-tumour therapies.

Conclusions:

• The use of complementary therapies in addition to conventional cancer treatment is associated with poorer patient outcomes.
• Reduced adherence to conventional treatment is a key factor mediating the negative impact of complementary therapies.
• Clinicians and patients must exercise caution, ensuring full adherence to prescribed anti-tumour treatments before considering complementary approaches.